Quick answer: Without insurance, tirzepatide costs about $125 to $499 a month in our table, depending on the route. Prices checked Oct 9–20, 2026.
- Zepbound (brand), LillyDirect vials or KwikPen: $299 at 2.5 mg, $399 at 5 mg, $449 at 7.5–15 mg if refilled within 45 days.
- Mounjaro (brand), LillyDirect single-dose pen: $499 a month at every dose (checked Oct 20, 2026); list price $1,112.16 per fill.
- Compounded tirzepatide: $125 to $432 a month all-in at the starting dose. Not FDA-approved.
Tirzepatide cost without insurance — at a glance
What this covers: Lilly's own prices for Zepbound and Mounjaro and every tirzepatide seller in our pricing dataset with a dated price, 25 options in all (Fella Health, not taking new patients, is left out). It is not every provider on the market. How it is sorted: by the lowest all-in monthly price at the 2.5 mg starting dose, on any plan length. A price that needs a prepaid plan says so. LillyDirect rows are medication only: you also need a prescriber.
| Option | FDA-approved or compounded | Starting-dose price | All-in monthly, incl. membership | At maintenance dose | First-year estimate* | Links |
|---|---|---|---|---|---|---|
| 1 Trimi Health | Compounded tirzepatide, weekly injection Compounded, not FDA-approved |
$125/mo if you pay for a year; $235 monthly | $125/mo, i.e. $1,500 for 12 months; 3 months $199/mo, 6 months $175/mo. Nothing else to pay | Unchanged at higher doses | $1,500 up front, or $2,820 at the monthly rate | Trimi tirzepatide prices Source: Trimi cost guide, checked Oct 20, 2026 |
| 2 Eden | Compounded tirzepatide, weekly injection Compounded, not FDA-approved |
$129, charged monthly | $129/mo; its GLP-1 page lists no membership, though its terms read Oct 13 still mentioned one ($39, then $99/mo), so check what checkout charges | Unchanged at higher doses (outside promotions) | Around $1,548, assuming no membership | Eden tirzepatide Source: Eden pricing, checked Oct 20, 2026 |
| 3 GobyMeds | Compounded tirzepatide, weekly injection Compounded, not FDA-approved |
$399 for 3 months at the first dose; one month $299+ | $133/mo through the 3-month bundle. Nothing else to pay | Goes up with the dose: $599 per bundle ($199.67/mo) at the top | Around $1,596 if the dose never rises | Our GobyMeds review Source: GobyMeds pricing, checked Oct 11, 2026 |
| 4 Amble | Compounded tirzepatide, weekly injection Compounded, not FDA-approved |
$135/mo over 12 months; $179 monthly | $135/mo, i.e. $1,620 for 12 months; $179 if paid monthly. Nothing else to pay | Unchanged at higher doses | $1,620 up front, or $2,148 at the monthly rate | Amble prices Source: Amble GLP-1 injections, checked Oct 20, 2026 |
| 4 Cora | Compounded tirzepatide, weekly injection Compounded, not FDA-approved |
$135/mo on the 12-month plan; $225 month-to-month | $135/mo ($1,620 upfront); $225 month-to-month. No membership | $135/mo (12-month) or $225 (monthly): the same price at every dose | $1,620 on the 12-month plan; $2,700 month-to-month | See Cora's prices Source: Cora's plans page, checked Oct 20, 2026 |
| 6 Mochi Health | Compounded tirzepatide, weekly injection Compounded, not FDA-approved |
$90/mo medication at the lowest dose | $139/mo: $90 + $49 membership (12-month membership, $588 upfront); $169 with the $79 monthly membership | $144 at 6.6 mg, up to $199 at the top dose, plus membership | About $2,237 (12-month membership; Mochi's 2.2, 4.4 and 6.6 mg tiers) | Our Mochi review Source: Mochi per-dose pricing, membership, checked Oct 20, 2026 |
| 7 Ivim Health | Compounded tirzepatide, weekly injection Compounded, not FDA-approved |
$117/mo on a 12-month program | $192/mo: $117 + $75 program fee (first month of the fee free) | Not published by dose | About $2,229 (12-month program + 11 months of the fee), if the program price holds | Our Ivim review Source: Ivim weight-loss pricing, checked Oct 20, 2026 |
| 8 SkinnyRx | Compounded tirzepatide, weekly injection Compounded, not FDA-approved |
$99 the first month, $299 after; $215/mo over 12 months | $215/mo over 12 months; $299 if paid monthly | Not listed by dose | Around $2,580 over 12 months | Our SkinnyRx review Source: SkinnyRx, checked Oct 11, 2026 |
| 9 Henry Meds | Compounded tirzepatide, daily dissolving tablet Compounded, not FDA-approved |
$234/mo on a 12-month plan paid upfront | $234/mo (12-month plan, paid in full). No membership. 3-month supply: $891 paid in full ($297/mo) or $1,047 ($349/mo) | Rises with dose; not published by dose | Not published | Our Henry Meds review Source: Henry Meds pricing, 3-month supply, checked Oct 20, 2026 |
| 10 Shed | Compounded tirzepatide, weekly injection Compounded, not FDA-approved |
$239/mo over 12 months; $299 monthly | $239/mo, i.e. $2,868 for 12 months; 6 months $269/mo; $299 if paid monthly | Not listed by dose | $2,868 up front | Our Shed review Source: Shed compounded tirzepatide, checked Oct 20, 2026 |
| 11 Fridays | Compounded tirzepatide, weekly injection Compounded, not FDA-approved |
$240/mo over a year; $359 monthly | $240/mo, i.e. $2,880 a year; $359 if paid monthly. Code-only promo prices ignored | Not listed by dose | $2,880 for the year | Fridays prices Source: Fridays pricing, checked Oct 20, 2026 |
| 12 LillyDirect | Zepbound single-dose vials (4 per month), weekly FDA-approved |
$299/mo at 2.5 mg; $399 at 5 mg | $299/mo, medication only; a prescriber visit, needles and syringes are extra | $449/mo at 7.5–15 mg if refilled within 45 days (otherwise $499 at 7.5 mg, $699 at 10–15 mg) | $5,188 + prescriber | Zepbound cost without insurance · LillyDirect prices Source: LillyDirect Zepbound, Lilly pricing, checked Oct 20, 2026 |
| 12 LillyDirect | Zepbound KwikPen (4 doses per pen), weekly FDA-approved |
$299/mo at 2.5 mg; $399 at 5 mg | $299/mo, medication only; prescriber visit and pen needles extra. Home delivery or Walmart pickup | $449/mo at 7.5–15 mg if refilled within 45 days (otherwise $499 to $699) | $5,188 + prescriber | LillyDirect prices Source: LillyDirect Zepbound, checked Oct 20, 2026 |
| 12 Noom Med | Compounded tirzepatide, weekly injection (GLP-1Rx Plus) Compounded, not FDA-approved |
$149 for the first 4 weeks, then $299/mo | $299/mo, billed quarterly; care and the Noom app included | Not stated by dose | About $3,588 if the price holds | Our Noom Med cost guide Source: Noom Med pricing, checked Oct 18, 2026 |
| 15 Sesame | Zepbound KwikPen or vial, weekly FDA-approved |
Zepbound from $299/mo | $358/mo: $59 membership (12-month commitment) + $299; $398 with the $99 monthly membership | Medication rises with dose | About $5,896 on the 12-month commitment, if the medication follows LillyDirect's prices | Sesame prices Source: Sesame weight-loss program, checked Oct 11, 2026 |
| 16 Ro | Zepbound KwikPen, weekly FDA-approved |
Zepbound from $299/mo | $373/mo: $74 membership (12-month, $888 upfront) + $299; $448 with the $149 monthly membership | Medication rises with dose; Ro does not list every dose on its main page | About $6,076 if the medication follows LillyDirect's prices | Our Ro review Source: Ro pricing, checked Oct 10, 2026 |
| 16 WeightWatchers Med+ | Zepbound KwikPen or vial, weekly FDA-approved |
Zepbound from $299/mo | $373/mo: $74 membership (12-month plan) + $299; $383 on the 6-month plan | Medication rises with dose | About $6,076 on the 12-month plan, if the medication follows LillyDirect's prices | WeightWatchers prices Source: WeightWatchers Med+ Zepbound, checked Oct 11, 2026 |
| 18 LifeMD | Zepbound vial, weekly FDA-approved |
Zepbound vial from $299/mo | $374/mo: program from $75 + $299; $448 on the $149 monthly program (first month $39) | Medication rises with dose | About $6,976 on the monthly program, if the medication follows LillyDirect's prices | Our LifeMD review Source: LifeMD membership page, checked Oct 9, 2026 |
| 19 TrimRx | Compounded tirzepatide, weekly injection Compounded, not FDA-approved |
$349 first month, then $399 per refill | $399/mo. No membership | Not stated by dose | About $4,788 if the price holds | Our TrimRx review Source: TrimRx terms, checked Oct 20, 2026 |
| 20 Remedy Meds | Compounded tirzepatide, weekly injection Compounded, not FDA-approved |
$279 to start, then $399 every 28 days | $432/mo as a calendar-month figure (13 charges of $399 a year) | Not listed by dose | Around $5,187 | Our Remedy Meds review Source: Remedy compounded tirzepatide, checked Oct 20, 2026 |
| 21 Hers | Zepbound KwikPen or vial, weekly FDA-approved |
Zepbound from $299/mo | $448/mo: $149 membership + $299 (first month membership $39) | Medication rises with dose | About $6,976 if the medication follows LillyDirect's prices | Our Hers review Source: Hers pricing, checked Oct 10, 2026 |
| 21 Hims | Zepbound KwikPen or vial, weekly FDA-approved |
Zepbound from $299/mo | $448/mo: $149 membership + $299 (first month membership $39) | Medication rises with dose | About $6,976 if the medication follows LillyDirect's prices | Our Hims review Source: Hims pricing, checked Oct 10, 2026 |
| 23 Calibrate | Zepbound KwikPen or vial, weekly FDA-approved |
Zepbound from $299/mo | $498/mo: $199 membership (3-month minimum) + $299. Calibrate does not publish a cash drug price; the medication figure is Lilly's self-pay price | Medication rises with dose | About $7,576, if the medication follows LillyDirect's prices | Calibrate prices Source: Calibrate pricing, checked Oct 11, 2026 |
| 24 LillyDirect | Mounjaro single-dose pens (4 per month), weekly; approved for type 2 diabetes FDA-approved |
$499/mo at 2.5 mg (LillyDirect lists it as "starting at") | $499/mo, medication only; a prescriber visit is extra. List price $1,112.16 per fill | $499/mo at every dose | $5,988 + prescriber | LillyDirect prices · Lilly Mounjaro pricing Source: LillyDirect Mounjaro, Lilly pricing (list price as of Jan 1, 2026), checked Oct 20, 2026 |
| – Medvi | Compounded tirzepatide, or Zepbound Compounded (not FDA-approved) or FDA-approved |
Compounded tirzepatide: no price on its site | Unverified, not ranked: Medvi's site showed no compounded tirzepatide price when we checked on Oct 20, 2026 (its injection tile lists semaglutide only); our Oct 11 figure was $399/mo. Zepbound plans: $99/mo membership + medication (not listed) | Not published | Not published | Our Medvi review Source: Medvi pricing, checked Oct 20, 2026 |
*First-year estimate is our arithmetic, not a quote: 1 month at 2.5 mg, 1 month at 5 mg, then 10 months at 7.5 mg (12 fills), at each seller's published prices, first-month promos left out. Your prescriber sets your dose. Compounded tirzepatide is not FDA-approved, has not been evaluated by the FDA for safety, effectiveness or quality, and is not therapeutically equivalent to Zepbound or Mounjaro. The seller's checkout is the final word on price.
Why tirzepatide prices rise with dose
Lilly prices Zepbound by dose. The weekly dose usually rises every 4 weeks, so the bill climbs in the first months:
| Dose | Refilled within 45 days | Otherwise |
|---|---|---|
| 2.5 mg (start) | $299 | $299 |
| 5 mg | $399 | $399 |
| 7.5 mg | $449 | $499 |
| 10, 12.5, 15 mg | $449 | $699 |
The vials are single-dose: you draw and inject the dose yourself with a syringe. Most compounded providers also charge more per dose, so verify whether the price holds as you titrate (see the tirzepatide dosage chart for the schedule). Amble, Cora, Eden (outside promotions) and Trimi Health are the exceptions in our table: the same price at every dose. Already on a vial? The tirzepatide dose calculator converts your prescribed dose to syringe units.
Mounjaro vs Zepbound — why the cost differs
Both are tirzepatide made by Eli Lilly, a once-weekly injection that acts on two gut hormone receptors (GIP and GLP-1). Mounjaro and Zepbound are the same active molecule at the same dose strengths; the difference is the approved use. Mounjaro is approved for type 2 diabetes and Zepbound for chronic weight management. Through LillyDirect, Zepbound vials and KwikPens cost $299–$449 a month and the Mounjaro single-dose pen $499 at every dose (checked Oct 20, 2026). For someone seeking weight-loss treatment without insurance, Zepbound is the lower-cost brand route. A licensed provider determines eligibility. According to the NIDDK, the usual criteria are a BMI of 30 or more, or 27 or more with a weight-related condition.
Compounded vs brand tirzepatide
- Not FDA-approved, not equivalent. Compounded tirzepatide is not reviewed by the FDA for safety, effectiveness or quality, and it is not the same as Zepbound or Mounjaro. The FDA has reported dosing errors and adverse events with compounded GLP-1s (FDA postmarket safety information). Published trial results, such as SURMOUNT-1's average 20.9% weight loss at 15 mg (Jastreboff et al., NEJM 2022), are for the branded drug.
- 503A vs 503B. Most telehealth tirzepatide comes from state-licensed 503A compounding pharmacies, which fill individual prescriptions. 503B outsourcing facilities register with the FDA and follow federal manufacturing standards (see FDA's human drug compounding framework).
- The shortage is over. The FDA declared the tirzepatide shortage resolved in December 2024 and ended the grace period for mass compounding in 2025. A 503A pharmacy may still compound for an individual patient's documented clinical need, not as a copy of Zepbound. In May 2026 the FDA proposed excluding tirzepatide from 503B bulk compounding; as of Oct 20, 2026 that is not final.
Compounded tirzepatide through telehealth costs less because there are no trials or brand pricing behind it, not because the evidence is equal. Compare the all-in price at your likely dose, the plan length and the named pharmacy. More: Compounded vs. Brand GLP-1 Cost, the cheapest GLP-1 cost comparison across semaglutide and tirzepatide, Buy tirzepatide online for the legitimate route, and cheapest compounded tirzepatide online.
Insurance, savings cards, and prior authorization
With commercial insurance that covers Zepbound, Lilly's savings card can bring it to as little as $25 a month (not for Medicare or Medicaid). Many plans exclude weight-loss drugs or require prior authorization with BMI and health records; see how to get a GLP-1 covered by insurance and Does Insurance Cover Wegovy and Zepbound? Eligible Medicare Part D members can get the Zepbound KwikPen for $50 a month through the Medicare GLP-1 Bridge through Dec 31, 2027 (see the current CMS announcement). Paying cash with pre-tax money? Prescribed medication can be a medical expense under IRC §213(d); see Can You Use HSA/FSA for a GLP-1?
Related cost guides
- GLP-1 Cost Guide 2026 (All Options): the GLP-1 cost guide for 2026 covers every drug
- Zepbound Cost Without Insurance
- Mounjaro cost without insurance: list price, LillyDirect and savings card in one dated table
- Compounded vs Brand GLP-1 Cost
- Cheapest Way to Get a GLP-1 (Cost Comparison)
- Tirzepatide vs Semaglutide
- Semaglutide Cost Guide
- Foundayo cost by dose: Lilly's daily GLP-1 pill, from $149/mo
Compare published GLP-1 prices →
Frequently asked questions
How much does tirzepatide cost per month without insurance?
Brand Zepbound from LillyDirect is $299 at 2.5 mg, $399 at 5 mg and $449 at 7.5–15 mg (refilled within 45 days); compounded tirzepatide runs $125 to $432 a month all-in in our table. Compounded tirzepatide is not FDA-approved.
Is tirzepatide cheaper than semaglutide?
Usually not: brand Zepbound starts at $299/mo versus $149 for the Wegovy pill and $349 for the Wegovy pen, and compounded tirzepatide generally costs more than compounded semaglutide at the same provider.
Is Zepbound or Mounjaro cheaper?
Paying cash, Zepbound: LillyDirect sells Zepbound vials and KwikPens for $299–$449/mo, and the Mounjaro single-dose pen for $499/mo at every dose. Both are tirzepatide, approved for different conditions.
How much does Mounjaro cost without insurance?
LillyDirect sells the Mounjaro single-dose pen for $499 a month at every dose (checked Oct 20, 2026), plus a prescriber visit. Its list price is $1,112.16 per 4-pen fill.
Why is Mounjaro so expensive?
Its list price is $1,112.16 per fill, but through LillyDirect the single-dose pen is $499 a month at every dose; Zepbound vials and KwikPens cost less at $299–$449.
How much is compounded tirzepatide?
In our table, $125 to $432 a month all-in at the starting dose, depending on the provider, plan length and membership fee. It is not FDA-approved and not therapeutically equivalent to Zepbound or Mounjaro.
Can you get tirzepatide without insurance?
Yes: with a prescription you can buy Zepbound vials or KwikPens through LillyDirect self-pay, or get compounded tirzepatide from a telehealth provider. Compounded tirzepatide is not FDA-approved.
Does FSA or HSA cover tirzepatide?
Often, when it is prescribed to treat a medical condition, since prescribed medication can be a qualified medical expense; confirm with your plan administrator.
What is the cheapest way to get tirzepatide?
With commercial coverage, the Zepbound savings card can bring it to as little as $25/mo. Without it, the lowest all-in price in our table is compounded tirzepatide from Trimi Health at $125/mo on an annual plan, and the lowest FDA-approved price is Zepbound from LillyDirect at $299/mo.
Does tirzepatide cost more at higher doses?
Often: Zepbound goes from $299 at 2.5 mg to $449 at 7.5 mg and above, and most compounded prices rise too. Amble, Cora, Eden and Trimi Health charge the same price at every dose.
How much is tirzepatide at Walmart?
LillyDirect self-pay Zepbound vials and KwikPens can be picked up at Walmart Pharmacy at the same $299–$449/mo LillyDirect price.
The bottom line
Brand tirzepatide costs $299 to $449 a month through LillyDirect (Zepbound), and $499 for the Mounjaro single-dose pen. Compounded tirzepatide runs $125 to $432 a month all-in in our table and is not FDA-approved. Compare the all-in price at the dose you will likely reach, not the starting price. Weighing semaglutide instead? See our tirzepatide vs semaglutide comparison. See what licensed providers charge. For every drug, see our full GLP-1 cost guide for 2026; on the FSA question, Can You Use HSA/FSA for a GLP-1?
Sources and references
- Provider prices: each seller's own site, linked in the table, checked Oct 9–20, 2026.
- LillyDirect: Zepbound self-pay vials and KwikPen (checked Oct 20, 2026)
- Zepbound self-pay vial pricing — Eli Lilly (pricinginfo.lilly.com) (checked Oct 20, 2026)
- LillyDirect: Mounjaro self-pay single-dose pen (checked Oct 20, 2026)
- Mounjaro pricing — Eli Lilly (pricinginfo.lilly.com) (checked Oct 20, 2026)
- Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. NEJM 2022 (SURMOUNT-1)
- FDA Human Drug Compounding — fda.gov
- FDA GLP-1 Postmarket Safety Information — fda.gov
- FDA: Policies for compounders as GLP-1 supply stabilizes
- NIDDK — Prescription Medications to Treat Overweight and Obesity
- CMS: Medicare GLP-1 Bridge Program — cms.gov
- IRS Publication 502: Medical and Dental Expenses
- GoodRx GLP-1 cost and savings guide
Compounded tirzepatide is not FDA-approved, has not been evaluated by the FDA for safety, effectiveness or quality, and is not therapeutically equivalent to Zepbound or Mounjaro. Not medical, financial or tax advice; a licensed provider determines eligibility. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly; Nouri is not affiliated with Eli Lilly. Nouri is a publisher; it does not prescribe or sell any medication.
Disclosure: Nouri may earn a commission when you sign up with some of the providers we link to. It doesn't change what you pay or how we rank providers. Every position in the table follows the method above. Full disclosure.
Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Nouri is an independent publisher: it does not prescribe, review patient assessments, or sell medication. Talk to a licensed clinician before starting or changing any medication or treatment.
Compare licensed GLP-1 providers
Published cash prices side by side, with the month we checked them and a link to each provider's own site. Nouri doesn't prescribe or sell medication.